Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
Armadillo: An emerging animal model for leprosy
Rahul Sharma U.S. Public Health Service National Hansen’s Disease Program LSU School of Veterinary Medicine Skip Bertman Drive Baton Rouge, LA 70803
EXPANDED RANGE OF ARMADILLO IN USA
150 yrs
•Develops fully
disseminated Disease
with extensive nerve
involvement
Nine banded armadillos
(Dasypus novemcinctus)
The only natural hosts
(other then Human) of M.
leprae.
HUMAN INTERECTION
The End
M. leprae Typing Scheme
3-I-2-v1 64%
3-I-2-v1 84%
Human
Armadillo
3-I-2 100%
ARMADILLOS: SOURCE OF ZOONOTIC TRANSMITION OF LEPROSY TO HUMANS
April 27, 2011
88% of Armadillos and 64% of US Human cases With endemic exposure Share the Sylvan strain
VN
TR
N Engl J Med 2011; 364:1626-1633
SNP
M. leprae: The causative agent of leprosy
Only known bacteria capable to invade nerves and induce neuro-
degeneration.
Still not cultivable in-vitro.
Available anti leprosy treatment (MDT) is very efficient bactericidal,
DOESN’T HELP IN NERVE DAMAGE.
Human nerve biopsy: un-ethical, not suitable for Molecular studies.
No other animal model develops leprosy and nerve damage.
ARMADILLO: The only host other than human.
The only immunologically intact host of M. leprae also recapitulates
leprosy as seen in human.
Host of choice to propagate M. leprae for research purpose.
The only animal model to study nerve damage in leprosy.
Genetically Identical quadruplets
Genome sequence available
LEPROSY AND ARMADILLO
Clinical symptoms
Nerve Physiology : MNCV and CMAP
Disseminated Infection
Morphometry
Nerve Fiber density
Comparative Histopathology
Gene expression profile
Global: Cross Species Microarray
Selected Marker: Inflammation, Nerve damage and Growth Factors
CHARACTERIZING THE NEUROPATHY IN ARMADILLOS
CLINICAL LEPROSY IN
HUMAN AND ARMADILLOS
Similar Ulceration in Human and Armadillo feet
Armadillo feet in late stage of laboratory infection
Human patient feet
NERVE FUNCTION ABNORMALITY
Motor Nerve Conduction Velocity (MNCV) and Compound Motor Action Potential (CMAP)
Standard technique identifies MNCV of <49m/sec as abnormal. Results of our sampling similarly suggest armadillo MNCV <40 m/s and CMAP <0.9mV are out of normal ranges.
Naïve Early infection
(6-9months)
Late infection (>2years)
MNCV CMAP MNCV CMAP MNCV CMAP
1
1-3 cm distal half of post tibial nerve
4-6 cm proximal half of post tibial nerve
Orientation of Posterior Tibial Nerve
Endoneurium Epineurioum
Ave
rag
e N
um
be
r o
f L
eu
ko
cyte
s
0
1
2
3
4
5
INFECTED
NAIVE
Degree of Inflammation: leukocyte counts in the posterior tibial nerve
Bacilli count in armadillo nerves by Q-PCR
1.00E+00
1.00E+01
1.00E+02
1.00E+03
1.00E+04
1.00E+05
1.00E+06T1
LtP
1-3
T1 L
tP 4
-6
T1 R
tP 1
-3
T1 R
tP 4
-6
T2 L
tP 1
-3
T2 L
tP 4
-6
T2 R
tP1-
3
T2 R
tP4-
6
T3 L
tP1
-3
T3 L
tP4
-6
T3 R
tP1-
3
T3 R
tP4-
6
T4 L
tP1
-3
T4 L
tP4
-6
T4 R
tP1-
3
T4 R
tP4-
6
T5 L
tP1
-3
T5 L
tP4
-6
T5 L
tP1
-3
T5 L
tP4
-6
I6 L
tP1
-3
I6 L
tP4
-6
I6 R
tP1
-3
I6 R
tP4
-6
I7 L
tP1
-3
I7 L
tP4
-6
I7 R
tP1
-3
I7 R
tP4
-6
I8 L
tP1
-3
I8 L
tP4
-6
I8 R
tP1
-3
I8 R
tP4
-6
I9 L
tP1
-3
I9 L
tP4
-6
I9 R
tP1
-3
I9 R
tP4
-6
I10
LtP
1-3
I10
LtP
4-6
I10
RtP
1-3
I10
tR
P4-
6
16S rRNA qRT-PCR
Treated with Rifampicin after developing the disease
Not treated after developing the disease
RLEP qPCR
Total number of myelinated fibers: Infected < naïve
Distribution of fibers: Infected: bimodal, Naïve: Single peak
De-myelination in infected Armadillo nerves
Elementary Morphometry To
tal n
um
be
r o
f fi
ber
s
Diameter of myelin around the axon (micron)
Lower* ENDF among infected animals
Epidermal Nerve Fiber Density (ENFD)
immunostained with PGP9.5, a neuronal marker
*not statistically significant
Cross species microarray hybridization
GENE EXPRESSION PROFILING OF INFECTED ARMADILLO NERVE
Infected Naïve
Human microarray (44K)
Functional classification of differentially regulated genes (>4fold)
Nerve damage in leprosy is a complex process involving various pathways
Neuregulin Signaling
MAPK Signaling
Chemokine Signaling
Ingenuity Pathway Analysis
Genomic Target Function Differential expressed in Condition Reference:
Beta III tubulin stability of the dimer in the microtubule. Response to NGF, colchicines, and mechanical injury J Cell Biol:112:303-312
Brain Res (2006)
1117:80-91
(GFAP) Glial
Fibrillary Acidic
Protein
Cell structure, movement,
communication, mitosis, and blood brain
barrier.
Burn injury BMC Infect Dis. 2008
Jun 24;8(1):84
MAG (Myelin-
Associated
Glycoprotein)
M yelination during nerve regeneration. Apotransferrin (aTf) Stimulation J Neurosci :2006;
26:7532-40
MBP
(Myelin Basic Protein) myelination of nerves CNS myelinogenesis
Physiol Behav. 2007 Sep
10;92(1-2):46-53
NCAM (Neural Cell
Adhesion Molecule)
neurite outgrowth during optic nerve regeneration Exp Neurol 2003, 182
(1):180-5
N-Cadherin At certain CNS synapses, presynaptic to
postsynaptic adhesion Regenerating visual structures
Exp.
Neurol.2002:177: Page
: 396-406
Neurofilament
major determinant of axonal caliber Accumulation of neurofilaments in neurons
Brain Res. (2000)
2;866(1-2):326-32.
Neuragulin development of the nervous system. Response to Schwann cell-derived neurotrophic factors J. Neurosci 2004:24:
6218-27
PGP9.5 (UCHL1)
normal synaptic and cognitive function Human prostate cancer cells express
Prostate. 2007 Dec
1;67(16):1761-9
PMP 22 (Peripheral
Myelin Protein) Expressed mainly in Schwann cells during de-myelination
J of Anatomy (2002)
200: 377 - 390
NGF β survival and maintenance of sympathetic
and sensory neurons. Traumatic Brain Injury J Trauma. 2008 Jun 19
DLK-1 Required for activation of MAPK Nerve Re generation Cell 2009;138:1005-
1018.
Neuronal markers selected for quantitative RT-PCR:
Development of quantitative RT-PCR
Human gene sequence was used as template to Retrieved Armadillo gene sequence
was used to design the Taq Man probe and primers.
Relative quantification by using ΔΔCt method
GAP3DH was used as normalizer
-2
-1.5
-1
-0.5
0
0.5
1
1.5
Log
RQ
Left distal half Left proximal half Right distal half Right proximal half
Differential expression of selected nerve marker during the active infection with M. leprae compared to naïve Armadillo nerve (n=5)
Infected vs Naive
• Inflammation,
• Upregulation of neuronal component ( Active damage / Repair effort)
• No activation of MAPK (no Regeneration)
armadillos treated with Rifampicin for one year compared to naïve armadillo
-2.5
-2
-1.5
-1
-0.5
0
0.5
1
PGP9.5 PMP 22 B Tubulin Neurofilament NCAM NGF B MAG DLK1 IFN TNF
Log
RQ
Left distal half Left proximal half Right distal half Right proximal half
After treatment
• Consistent Inflammation even after treatment
• No activation of MAPK (no Regeneration)
Intra-neural Inoculation of M. leprae in Nine-banded
Armadillos (Dasypus novemcinctus).
Surgical removal, Orientation and gene expression
at various time points after infection
AFB and histopathology
Molecular enumeration
Q-RT-PCR
• In deep anaesthesia, post tibial nerve
was exposed
• Total 107 M. leprae were injected
directly into the nerves of 14 armadillos.
• Nerves were surgically removed in pairs
at 3, 7, 14, 21, 30, 60 and 90 days post
inoculation.
A
Fig 2
A
Enumeration of M. leprae at different time points after intraneural innoculation
3 Day
s
17 D
ays
21 D
ays
30 D
ays
60 D
ays
90 D
ays
Baculli /
cm
of
nerv
e
1e+1
1e+2
1e+3
1e+4
1e+5
1e+6
1e+7
Distal 3 cm
Poteriar 3 cm
Greater involvement of distal nerve
No Acid Fast Bacilli (AFB) in microscopy.
Total number of bacteria retain in the nerve (~ 9.18+3 M. leprae ) was significantly lower
than natural or intra-venous Infection (9.3E+04 bacilli/mm of nerve).
IFN-
Nai
ve
3 Day
s
17 D
ays
21 D
ays
30 D
ays
60 D
ays
90 D
ays
Lo
g R
Q
-1.0
-0.5
0.0
0.5
1.0
1.5
2.0
TNF-
Nai
ve
3 Day
s
17 D
ays
21 D
ays
30 D
ays
60 D
ays
90 D
ays
Lo
g R
Q
-1.5
-1.0
-0.5
0.0
0.5
1.0
1.5
2.0
DLK-1
Nai
ve
3 Day
s
17 D
ays
21 D
ays
30 D
ays
60 D
ays
90 D
ays
Lo
g R
Q
-2.5
-2.0
-1.5
-1.0
-0.5
0.0
0.5
1.0
1.5
NGF
X Data
Naive
3 Days
17 Days
21 Days
30 Days
60 Days
90 Days
Lo
g R
Q
-4
-3
-2
-1
0
1
A B
C D
Higher cytokine production
Down regulation of Regeneration and Growth factors
CONCLUSIONS: Nerve damage in leprosy is the result of :
Inflammation,
Demyelination / degeneration
Failure of regeneration efforts
Armadillo is an animal model for:
Study molecular events associated with neuropathy.
reproducing the observation seen in-vitro and other
in-vivo intervention studies.
Test any neuro-regenerative or protective Agents.
Acknowledgments:
Dr. R. Truman, PhD Dr. D Williams, PhD Dr. T Gillis, PhD Dr. R Lahiri, PhD
Dr. D Scollard, PhD
Maria Penna Tana Pittman Kile Andrew Ale All others
Armadillo Contract and NHDP for grants